How GLP-1 Drugs Affect What People with Diabetes Actually Eat

Adults with type 2 diabetes on GLP-1 drugs showed different dietary patterns and Mediterranean diet adherence compared to those on other medications.

Ponzo, Valentina et al.·Nutrients·2025·low-moderateObservational
RPEP-13079Observationallow-moderate2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Observational
Evidence
low-moderate
Sample
N=N=103
Participants
Adults with type 2 diabetes attending a clinic in Turin, Italy (mean age 66, 65% male)

What This Study Found

GLP-1 RA users showed differences in dietary intake and Mediterranean diet adherence compared to patients on other diabetes medications.

Key Numbers

N=103; 50.5% on GLP-1 RAs; fiber ~11 g/1000 kcal; fat ~39-40% of energy; saturated fat <10%.

How They Did This

Cross-sectional study of 103 T2D adults using validated food frequency questionnaires and Mediterranean Diet Score.

Why This Research Matters

If GLP-1 drugs change dietary patterns, nutritional counseling may need to be adapted to prevent nutrient deficiencies in long-term users.

The Bigger Picture

Understanding the nutritional impact of appetite-suppressing drugs is essential as millions use GLP-1 medications long-term.

What This Study Doesn't Tell Us

Cross-sectional design cannot determine causation. Single-center Italian cohort may not generalize globally. Self-reported dietary data.

Questions This Raises

  • ?Do GLP-1 users need specific nutritional supplementation?
  • ?Does dietary quality improve or worsen with prolonged appetite suppression?

Trust & Context

Key Stat:
103 patients Dietary patterns compared between GLP-1 RA users and other diabetes medication users in Turin, Italy
Evidence Grade:
Cross-sectional study with validated dietary tools — useful for hypothesis generation but cannot prove GLP-1 drugs cause dietary changes.
Study Age:
Published in 2025 with data collected in 2025 — reflects very current prescribing patterns.
Original Title:
Exploring Dietary Intake in Adults with Type 2 Diabetes Using GLP-1 Receptor Agonists: A Cross-Sectional Analysis.
Published In:
Nutrients, 17(21) (2025)
Database ID:
RPEP-13079

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Watches what happens naturally without intervening.

What do these levels mean? →

Frequently Asked Questions

Do GLP-1 drugs change what you eat, not just how much?

This study found differences in dietary patterns between GLP-1 users and non-users, suggesting these drugs may influence food choices beyond just appetite.

Should I see a dietitian if I start a GLP-1 medication?

Given that appetite suppression can affect nutrient intake, working with a dietitian can help ensure nutritional adequacy while on GLP-1 therapy.

Read More on RethinkPeptides

Cite This Study

RPEP-13079·https://rethinkpeptides.com/research/RPEP-13079

APA

Ponzo, Valentina; Vitale, Marilena; Bo, Simona; Broglio, Fabio; Goitre, Ilaria; Cioffi, Iolanda. (2025). Exploring Dietary Intake in Adults with Type 2 Diabetes Using GLP-1 Receptor Agonists: A Cross-Sectional Analysis.. Nutrients, 17(21). https://doi.org/10.3390/nu17213318

MLA

Ponzo, Valentina, et al. "Exploring Dietary Intake in Adults with Type 2 Diabetes Using GLP-1 Receptor Agonists: A Cross-Sectional Analysis.." Nutrients, 2025. https://doi.org/10.3390/nu17213318

RethinkPeptides

RethinkPeptides Research Database. "Exploring Dietary Intake in Adults with Type 2 Diabetes Usin..." RPEP-13079. Retrieved from https://rethinkpeptides.com/research/ponzo-2025-exploring-dietary-intake-in

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.